2026-01-13
Abstract:SUZHOU, China, January 13, 2026 — GenHouse Bio Co., Ltd., a clinical-stage biotechnology company dedicated to developing next-generation small-molecule oncology therapies via integrated technology platforms, today announced the successful completion of a crossover financing round exceeding RMB 300 million. The round was led by GreenPine Capital Partners, with participation from a syndicate of prominent investors including LinZhuo Investment, YuanBio Venture Capital, Guangzhou Industrial Investment, VIVATEC, BoHe Angel Fund, Guoju Entrepreneurship Investment.
AI-Driven R&D and High-Efficiency Innovation
As an innovation-driven biotech company, GenHouse Bio remains steadfast in its focus on developing world-leading targeted small-molecule anti-tumor drugs. The company has built a drug-discovery philosophy of “AI/Biology-Driven Smart Design,” deeply integrating computational chemistry, artificial intelligence, and in-house experimental platforms to create an efficient, data-driven, rapidly iterative R&D system that empowers the entire process from drug discovery to clinical development.
Differentiated Pipeline and Clinical Progress
GenHouse Bio has established differentiated pipelines covering the Ras signaling pathway and synthetic-lethal fields, advancing multiple world-leading programs into clinical stages. This demonstrates its sustained innovation capability and is expected to provide internationally competitive solutions for precision and combination therapies of refractory tumors. The company’s platform capabilities and pipeline potential have earned prestigious recognitions, including the "Gusu Major Innovation Team" and "Jiangsu Provincial Major Project" awards. Furthermore, GenHouse Bio has participated in the "National Key Science and Technology Program for Innovative Drug Development," reflecting broad institutional validation of its technical roadmap and innovative value.
Strategic Outlook
The completion of this financing round will further accelerate the company’s R&D progress and strategic layout. Looking ahead, GenHouse Bio will continue to leverage its AI-empowered highly efficient innovative system to address unmet clinical needs. By collaborating with partners across industry, academia, and research partners, the company remains committed to advancing globally competitive innovative drugs and delivering breakthrough treatment solutions to patients worldwide.
About Genhouse
Suzhou Genhouse Bio Co., Ltd. is a clinical-stage biotech company based in China dedicated to the discovery and development of innovative therapies for cancer. The company leverages its combination of research platforms to advance a pipeline of differentiated drug candidates for global markets.
Genhouse Bio (Suzhou) Ltd. (“Genhouse” or “We”) respects the privacy of visitors (“Users”) to our website www.genhousebio.com (“Site”), so we have developed this website privacy statement (“Privacy Statement”). This Privacy Statement indicates what information we collect about you and how that information is used. We may update the content of the Privacy Statement and suggest reading it regularly when you visit our Site.
Personal Information Collected by Genhouse
When you visit the Site, usually we will not collect any personal information from you. We might track your DNS and analyze the data to obtain understanding on visit trends. However, your identity will always remain anonymous, unless you specifically and knowingly provide it to us. When you provide such information, we will collect your personal information, such as when you contact us through the phone number or email address posted on the Site. But no matter when and how we collect your personal information, we will always provide link to this Privacy Statement. By willingly providing your personal information to us, you make the consent that we could use the information collected according to this Privacy Statement and admit that the information will be transferred from your locale to our office or server.
Information Disclosures and Sharing
Except as provided below, we will not share or sell your Personal Information with third parties unless otherwise stated by this Privacy Statement.
We might share your information according to this Privacy Statement, with Related Party who have consented to follow this Privacy Statement. Your personal information might also be transferred to other Related Party who represents us for purpose stated when we collect those information or other purposes permitted by law, such as Site evaluation, data management or technical support.
We might sell or buy business or assets during our operation. If Genhouse is acquired, merged, reorganized or dissolved or other alike situations happened, personal information might be part of the assets transferred. We may share personal information to respond to duly authorized subpoenas or other lawful information requests of governmental authorities, including to meet national security or law enforcement requirements, to provide Internet security, or where required by law.
Cookies
We might put a digital tag (more precisely “cookies”) on your hard disk driver for the server to recognize your computer and track usage information. Cookies will not reveal your personal information and you could always stay anonymous to us. The information we collected from Cookies will only be used for internal purpose and improve the service we provided to you through the Site. Users of our Site always have the option of disabling cookies via their browser preferences. If under any circumstances we collected your personal information, we will always inform you with your planned usage, contact and any Third Party that might get this information. All your personal information will maintain secrecy.
Links to Other Websites
If you apply to a job through our Site, you might be directed to other websites operated by Third Party. This Privacy Statement does not extend to any of these websites. Genhouse will not be responsible for any personal information collected by these websites operated by Third Party. Therefore, for any cases that a Third Party collect or use your personal information, Genhouse will not be legally responsible. We advise you to contact those websites directly and get their policies on personal information collection, safety, sharing and disclosure.
Contact Information
If you have any questions about our Privacy Statement, please do not hesitate to contact us at [infor@genhousebio.com].
Effective and Last Updated: April 15th 2021
